Skip to main content
SpringerLink
Log in

Aging and Cancer: What Oncologists Need to Know

  • Chapter
  • First Online:
Book cover Geriatric Oncology

Cancer is a disease associated with aging. Approximately 60% of cancer diagnoses and 70% of cancer mortalities occur in patients age 65 or older. By 2011 in the United States, the “Baby Boomer” generation will be turning 65. The aging of these baby boomers, along with a rise in the overall life expectancy, is leading to a rapid growth of the older U.S. population. By 2030, one in five Americans will be age 65 or older. These demographics, along with the known association between cancer and aging, will contribute to an enormous rise in the number of older adults with cancer. Incorporating geriatric principles of care will be increasingly essential to cancer treatment.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Diab SG, Elledge RM, Clark GM. Tumor characteristics and clinical outcome of elderly women with breast cancer. J Natl Cancer Inst 2000;92(7):550–6.

    Article  PubMed  CAS  Google Scholar 

  2. Anders CK, Hsu DS, Broadwater G, et al. Young age at diagnosis correlates with worse prognosis and defines a subset of breast cancers with shared patterns of gene expression. J Clin Oncol 2008;26 (20):3324–30.

    Article  PubMed  Google Scholar 

  3. Estey E. Acute myeloid leukemia and myelodysplastic syndromes in older patients. J Clin Oncol 2007;25 (14):1908–15.

    Article  PubMed  Google Scholar 

  4. Hutchins LF, Unger JM, Crowley JJ, Coltman CA, Jr., Albain KS. Underrepresentation of patients 65 years of age or older in cancer-treatment trials. N Engl J Med 1999;341 (27):2061–7.

    Article  PubMed  CAS  Google Scholar 

  5. Yee KW, Pater JL, Pho L, Zee B, Siu LL. Enrollment of older patients in cancer treatment trials in Canada: Why is age a barrier? J Clin Oncol 2003;21 (8):1618–23.

    Article  PubMed  Google Scholar 

  6. Trimble EL, Carter CL, Cain D, Freidlin B, Ungerleider RS, Friedman MA. Representation of older patients in cancer treatment trials. Cancer 1994;74 (7 Suppl):2208–14.

    Article  PubMed  CAS  Google Scholar 

  7. Muss HB, Berry DA, Cirrincione C, et al. Toxicity of older and younger patients treated with adjuvant chemotherapy for node-positive breast cancer: The Cancer and Leukemia Group B Experience. J Clin Oncol 2007;25 (24):3699–704.

    Article  PubMed  CAS  Google Scholar 

  8. Sawhney R, Sehl M, Naeim A. Physiologic aspects of aging: Impact on cancer management and decision making, part I. Cancer J 2005;11 (6):449–60.

    Article  PubMed  Google Scholar 

  9. Sehl M, Sawhney R, Naeim A. Physiologic aspects of aging: Impact on cancer management and decision making, part II. Cancer J 2005;11 (6):461–73.

    Article  PubMed  Google Scholar 

  10. Vestal RE. Aging and pharmacology. Cancer 1997;80 (7):1302–10.

    Article  PubMed  CAS  Google Scholar 

  11. Lindeman RD, Tobin J, Shock NW. Longitudinal studies on the rate of decline in renal function with age. J Am Geriatr Soc 1985;33 (4):278–85.

    PubMed  CAS  Google Scholar 

  12. Fehrman-Ekholm I, Skeppholm L. Renal function in the elderly (>70 years old) measured by means of iohexol clearance, serum creatinine, serum urea and estimated clearance. Scand J Urol Nephrol 2004;38 (1):73–7.

    Article  PubMed  CAS  Google Scholar 

  13. Avorn J, Gurwitz, JH. Geriatric Medicine. Springer-Verlag, New York. 1997.

    Google Scholar 

  14. Baker SD, van Schaik RH, Rivory LP, et al. Factors affecting cytochrome P-450 3A activity in cancer patients. Clin Cancer Res 2004;10 (24):8341–50.

    Article  PubMed  CAS  Google Scholar 

  15. Hunt CM, Westerkam WR, Stave GM. Effect of age and gender on the activity of human hepatic CYP3A. Biochem Pharmacol 1992;44 (2):275–83.

    Article  PubMed  CAS  Google Scholar 

  16. Schwartz JB. Race but not age affects erythromycin breath test results in older hypertensive men. J Clin Pharmacol 2001;41 (3):324–9.

    Article  PubMed  CAS  Google Scholar 

  17. Sotaniemi EA, Arranto AJ, Pelkonen O, Pasanen M. Age and cytochrome P450-linked drug metabolism in humans: An analysis of 226 subjects with equal histopathologic conditions. Clin Pharmacol Ther 1997;61 (3):331–9.

    Article  PubMed  CAS  Google Scholar 

  18. Yuen GJ. Altered pharmacokinetics in the elderly. Clin Geriatr Med 1990;6 (2):257–67.

    PubMed  CAS  Google Scholar 

  19. Baker SD, Grochow LB. Pharmacology of cancer chemotherapy in the older person. Clin Geriatr Med 1997;13 (1):169–83.

    PubMed  CAS  Google Scholar 

  20. Lichtman SM, Hollis D, Miller AA, et al. Prospective evaluation of the relationship of patient age and paclitaxel clinical pharmacology: Cancer and Leukemia Group B (CALGB 9762). J Clin Oncol 2006;24 (12):1846–51.

    Article  PubMed  CAS  Google Scholar 

  21. ten Tije AJ, Verweij J, Carducci MA, et al. Prospective evaluation of the pharmacokinetics and toxicity profile of docetaxel in the elderly. J Clin Oncol 2005;23 (6):1070–7.

    Article  PubMed  Google Scholar 

  22. Dees EC, O'Reilly S, Goodman SN, et al. A prospective pharmacologic evaluation of age-related toxicity of adjuvant chemotherapy in women with breast cancer. Cancer Invest 2000;18 (6):521–9.

    Article  PubMed  CAS  Google Scholar 

  23. Jen JF, Cutler DL, Pai SM, et al. Population pharmacokinetics of temozolomide in cancer patients. Pharm Res 2000;17 (10):1284–9.

    Article  PubMed  CAS  Google Scholar 

  24. Smith TJ, Khatcheressian J, Lyman GH, et al. Update of recommendations for the use of white blood cell growth factors: An evidence-based clinical practice guideline. J Clin Oncol 2006;24 (19):3187–205.

    Article  PubMed  CAS  Google Scholar 

  25. Gomez H, Hidalgo M, Casanova L, et al. Risk factors for treatment-related death in elderly patients with aggressive non-Hodgkin's lymphoma: Results of a multivariate analysis. J Clin Oncol 1998;16 (6):2065–9.

    PubMed  CAS  Google Scholar 

  26. Balducci L, Al-Halawani H, Charu V, et al. Elderly cancer patients receiving chemotherapy benefit from first-cycle pegfilgrastim. Oncologist 2007;12 (12):1416–24.

    Article  PubMed  CAS  Google Scholar 

  27. Mancuso A, Migliorino M, De Santis S, Saponiero A, De Marinis F.Correlation between anemia and functional/cognitive capacity in elderly lung cancer patients treated with chemotherapy. Ann Oncol 2006;17 (1):146–50.

    Article  PubMed  CAS  Google Scholar 

  28. Rao AV, Cohen HJ. Fatigue in older cancer patients: Etiology, assessment, and treatment. Sem Oncol 2008;35 (6):633–42.

    Article  Google Scholar 

  29. Reuben DB, Rubenstein LV, Hirsch SH, Hays RD. Value of functional status as a predictor of mortality: Results of a prospective study. Am J Med 1992;93 (6):663–9.

    Article  PubMed  CAS  Google Scholar 

  30. Inouye SK, Peduzzi PN, Robison JT, Hughes JS, Horwitz RI, Concato J. Importance of functional measures in predicting mortality among older hospitalized patients. J Am Med Assoc 1998;279 (15):1187–93.

    Article  CAS  Google Scholar 

  31. Stafford RS, Cyr PL. The impact of cancer on the physical function of the elderly and their utilization of health care. Cancer 1997;80 (10):1973–80.

    Article  PubMed  CAS  Google Scholar 

  32. Keating NL, Norredam M, Landrum MB, Huskamp HA, Meara E. Physical and mental health status of older long-term cancer survivors. J Am Geriatr Soc 2005;53 (12):2145–52.

    Article  PubMed  Google Scholar 

  33. Audisio RA, Ramesh H, Longo WE, Zbar AP, Pope D. Preoperative assessment of surgical risk in oncogeriatric patients. Oncologist 2005;10 (4):262–8.

    Article  PubMed  Google Scholar 

  34. Maione P, Perrone F, Gallo C, et al. Pretreatment quality of life and functional status assessment significantly predict survival of elderly patients with advanced non-small-cell lung cancer receiving chemotherapy: A prognostic analysis of the multicenter Italian lung cancer in the elderly study. J Clin Oncol 2005;23 (28):6865–72.

    Article  PubMed  Google Scholar 

  35. Freyer G, Geay JF, Touzet S, et al. Comprehensive geriatric assessment predicts tolerance to chemotherapy and survival in elderly patients with advanced ovarian carcinoma: A GINECO study. Ann Oncol 2005;16 (11):1795–800.

    Article  PubMed  CAS  Google Scholar 

  36. Extermann M, Balducci L, Lyman GH. What threshold for adjuvant therapy in older breast cancer patients? J Clin Oncol 2000;18 (8):1709–17.

    PubMed  CAS  Google Scholar 

  37. Frasci G, Lorusso V, Panza N, et al. Gemcitabine plus vinorelbine versus vinorelbine alone in elderly patients with advanced non-small-cell lung cancer. J Clin Oncol 2000;18 (13):2529–36.

    PubMed  CAS  Google Scholar 

  38. Firat S, Bousamra M, Gore E, Byhardt RW. Comorbidity and KPS are independent prognostic factors in stage I non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 2002;52 (4):1047–57.

    Article  PubMed  Google Scholar 

  39. Piccirillo JF, Tierney RM, Costas I, Grove L, Spitznagel EL, Jr. Prognostic importance of comorbidity in a hospital-based cancer registry. J Am Med Assoc 2004;291 (20):2441–7.

    Article  CAS  Google Scholar 

  40. Satariano WA, Ragland DR. The effect of comorbidity on 3-year survival of women with primary breast cancer. Ann Intern Med 1994;120 (2):104–10.

    PubMed  CAS  Google Scholar 

  41. Steyerberg EW, Neville BA, Koppert LB, et al. Surgical mortality in patients with esophageal cancer: Development and validation of a simple risk score. J Clin Oncol 2006;24 (26):4277–84.

    Article  PubMed  Google Scholar 

  42. Birim O, Kappetein AP, van Klaveren RJ, Bogers AJ. Prognostic factors in non-small cell lung cancer surgery. Eur J Surg Oncol 2006;32 (1):12–23.

    Article  PubMed  CAS  Google Scholar 

  43. Meyerhardt JA, Catalano PJ, Haller DG, et al. Impact of diabetes mellitus on outcomes in patients with colon cancer. J Clin Oncol 2003;21 (3):433–40.

    Article  PubMed  Google Scholar 

  44. Hammarsten J, Hogstedt B. Hyperinsulinaemia: A prospective risk factor for lethal clinical prostate cancer. Eur J Cancer 2005;41 (18):2887–95.

    Article  PubMed  CAS  Google Scholar 

  45. Goodwin PJ, Ennis M, Pritchard KI, et al. Fasting insulin and outcome in early-stage breast cancer: Results of a prospective cohort study. J Clin Oncol 2002;20 (1):42–51.

    Article  PubMed  CAS  Google Scholar 

  46. Pavelka JC, Brown RS, Karlan BY, et al. Effect of obesity on survival in epithelial ovarian cancer. Cancer 2006;107 (7):1520–4.

    Article  PubMed  Google Scholar 

  47. Kaklamani VG, Wisinski KB, Sadim M, et al. Variants of the adiponectin (ADIPOQ) and adiponectin receptor 1 (ADIPOR1) genes and colorectal cancer risk. J Am Med Assoc 2008;300 (13):1523–31.

    Article  CAS  Google Scholar 

  48. Lee SJ, Lindquist K, Segal MR, Covinsky KE. Development and validation of a prognostic index for 4-year mortality in older adults. J Am Med Assoc 2006;295 (7):801–8.

    Article  CAS  Google Scholar 

  49. Charlson M, Szatrowski TP, Peterson J, Gold J. Validation of a combined comorbidity index. J Clin Epidemiol 1994;47 (11):1245–51.

    Article  PubMed  CAS  Google Scholar 

  50. Walter LC, Brand RJ, Counsell SR, et al. Development and validation of a prognostic index for 1-year mortality in older adults after hospitalization. J Am Med Assoc 2001;285 (23):2987–94.

    Article  CAS  Google Scholar 

  51. Seeman TE, Berkman LF, Kohout F, Lacroix A, Glynn R, Blazer D. Intercommunity variations in the association between social ties and mortality in the elderly. A comparative analysis of three communities. Ann Epidemiol 1993;3 (4):325–35.

    Article  PubMed  CAS  Google Scholar 

  52. Kornblith AB, Herndon JE, 2nd, Zuckerman E, et al. Social support as a buffer to the psychological impact of stressful life events in women with breast cancer. Cancer 2001;91 (2):443–54.

    Article  PubMed  CAS  Google Scholar 

  53. Kornblith AB, Herndon JE, 2nd, Weiss RB, et al. Long-term adjustment of survivors of early-stage breast carcinoma, 20 years after adjuvant chemotherapy. Cancer 2003;98 (4):679–89.

    Article  PubMed  Google Scholar 

  54. Braun M, Mikulincer M, Rydall A, Walsh A, Rodin G. Hidden morbidity in cancer: Spouse caregivers. J Clin Oncol 2007;25 (30):4829–34.

    Article  PubMed  Google Scholar 

  55. Rhee YS, Yun YH, Park S, et al. Depression in family caregivers of cancer patients: The feeling of burden as a predictor of depression. J Clin Oncol 2008;26 (36):5890-5.

    Google Scholar 

  56. Kua J. The prevalence of psychological and psychiatric sequelae of cancer in the elderly—How much do we know? Ann Acad Med Singapore 2005;34 (3):250–6.

    PubMed  CAS  Google Scholar 

  57. Penninx BW, Guralnik JM, Ferrucci L, Simonsick EM, Deeg DJ, Wallace RB. Depressive symptoms and physical decline in community-dwelling older persons. J Am Med Assoc 1998;279 (21):1720–6.

    Article  CAS  Google Scholar 

  58. Langa KM, Valenstein MA, Fendrick AM, Kabeto MU, Vijan S. Extent and cost of informal caregiving for older Americans with symptoms of depression. Am J Psychiatry 2004;161 (5):857–63.

    Article  PubMed  Google Scholar 

  59. Vinokur AD, Threatt BA, Vinokur-Kaplan D, Satariano WA. The process of recovery from breast cancer for younger and older patients. Changes during the first year. Cancer 1990;65 (5):1242–54.

    Article  PubMed  CAS  Google Scholar 

  60. Miller M, Mogun H, Azrael D, Hempstead K, Solomon DH. Cancer and the risk of suicide in older Americans. J Clin Oncol 2008;26 (29):4720–4.

    Article  PubMed  Google Scholar 

  61. Wolfson C, Wolfson DB, Asgharian M, et al. A reevaluation of the duration of survival after the onset of dementia. N Engl J Med 2001;344 (15):1111–6.

    Article  PubMed  CAS  Google Scholar 

  62. Gupta SK, Lamont EB. Patterns of presentation, diagnosis, and treatment in older patients with colon cancer and comorbid dementia. J Am Geriatr Soc 2004;52 (10):1681–7.

    Article  PubMed  Google Scholar 

  63. Gorin SS, Heck JE, Albert S, Hershman D. Treatment for breast cancer in patients with Alzheimer's disease. J Am Geriatr Soc 2005;53 (11):1897–904.

    Article  PubMed  Google Scholar 

  64. Hurria A, Goldfarb S, Rosen C, et al. Effect of adjuvant breast cancer chemotherapy on cognitive function from the older patient's perspective. Breast Cancer Res Treat 2006;98 (3):343–8.

    Article  PubMed  CAS  Google Scholar 

  65. Fried TR, Bradley EH, Towle VR, Allore H. Understanding the treatment preferences of seriously ill patients. N Engl J Med 2002;346 (14):1061–6.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. City of Hope National Medical Center, Duarte, CA, USA

    Arti Hurria

  2. H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA

    Lodovico Balducci

Authors
  1. Arti Hurria
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Lodovico Balducci
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Arti Hurria .

Editor information

Editors and Affiliations

  1. City of Hope National Medical Center, E. Duarte Road 1500 , Duarte, 91010-3000, U.S.A.

    Arti Hurria

  2. Research Institute, H. Lee Moffitt Cancer Center &, Magnolia Drive 12902, Tampa, 33612, U.S.A.

    Lodovico Balducci

Rights and permissions

Reprints and permissions

Copyright information

© 2009 Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Hurria, A., Balducci, L. (2009). Aging and Cancer: What Oncologists Need to Know. In: Hurria, A., Balducci, L. (eds) Geriatric Oncology. Springer, Boston, MA. https://doi.org/10.1007/978-0-387-89070-8_1

Download citation

  • DOI: https://doi.org/10.1007/978-0-387-89070-8_1

  • Published:

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-0-387-89069-2

  • Online ISBN: 978-0-387-89070-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation